Document is current
Any future updates will be listed below
-
Authors
Ingram, Thomas https://orcid.org/0000-0003-2319-9342
Sengupta, Raj https://orcid.org/0000-0002-9720-0396
Standage, Martyn https://orcid.org/0000-0002-9683-8590
Barnett, Rosie https://orcid.org/0000-0002-2215-4970
Rouse, Peter https://orcid.org/0000-0001-8761-4299
-
Funding
Funding for this research was provided by:
Bath Institute for Rheumatic Diseases (RAG-PR-33-120318)
- License Information
-
More Information
Article History
Received: 31 March 2022
Accepted: 30 April 2022
First Online: 8 June 2022
Declarations
:
: Dr. Raj Sengupta has previously held unrelated grants from UCB, Pfizer, Abbvie and Novartis and received honoraria for giving talks from Abbvie, Biogen, Lilly, UCB, Novartis and Pfizer. Rosie Barnett has received unrelated funding from UCB. Thomas Ingram, Prof. Martyn Standage, and Dr. Peter Rouse have no disclosures.
